Fig 1.
Flowchart illustrating the screening and enrollment process for study participants.
Table 1.
Characteristics of patients with SAE.
Fig 2.
Sedatives. (A) Original cohort; (B) Matched cohort.
Table 2.
Association between sedative use and the one-year all-cause mortality of patients with SAE.
Fig 3.
Kaplan-Meier survival curves between the sedative use and non-sedative use groups. (A) Original cohort; (B) Matched cohort.
Fig 4.
Kaplan-Meier survival curves between the different sedatives and non-sedative groups. (A) monotherapy; (B) combinations.
Fig 5.
The effect size of sedative use on one-year all-cause mortality of patients with SAE in each subgroup.
Fig 6.
The effect size of propofol monotherapy on one-year all-cause mortality of patients with SAE in each subgroup.